Pure Global Cannabis Inc. (TSXV:PURE; OTC: PRCNF; FRA:1QS) (“Pure Global”) an integrated, growth-oriented life sciences and consumer products cannabis company, through its wholly-owned subsidiary PureSinse Inc. (“PureSinse” or “Company”), a Health Canada licensed producer under The Cannabis Act, is pleased to announce a partnership with Velvet Management Inc. (“Velvet”), to be its Canadawide sales and distribution agent for its premium wellness, recreational, and craft cannabis products to be sold through provincially licensed stores and online retailers.

Velvet, a company created by the largest wine distributor in Canada, Philippe Dandurand Wines Ltd. (“Dandurand”), will serve to ensure a strong retail and brand presence for Pure Global’s non-medical lines of cannabis products with provincially regulated channels. With sales teams in every province, Velvet brings a deep expertise with driving brand visibility and commercial retail presence.

Dandurand is the largest wine importer/agent in Canada, responsible for over 4 million cases or $625 million of annual sales volume across 3,000 retail points, with the largest wine salesforce in the country. One in ten imported bottles of wine in Canada is sold by Dandurand. In operation for over fifty years, with 125 employees in Calgary, Montreal, Toronto, and Vancouver, Dandurand has won Partner of the Year for the last three years by the Liquor  Control Board of Ontario(“LCBO”). The LCBO operates the Ontario Cannabis Store and will distribute cannabis to provincially licensed retailers. Velvet Management is dedicated to the cannabis sector and will duplicate the model that achieved them the number one status in the wine category.

Velvet will soon have over 40 experienced sales representatives to service the close to two thousand licensed retail locations soon expected across Canada. Velvet has established direct relationships with provincial wholesalers and retail operators in all provinces giving Pure Global’s branded portfolio immediate, direct access to each point of distribution in Canada’s consumer Cannabis market, with exclusivity for the premium and craft product categories.

“This is significant for our sales, distribution, and route to market strategy to expedite our reach to provincially licensed retailers,” said Malay Panchal, CEO of Pure Global. “Velvet’s highly professional and experienced team was an obvious choice when further asking who has the track record to make us leaders in every product category we want to enter,” Panchal further added.

“This partnership is a tremendous step forward for us and provides our premium and craft brands with experienced sales and distribution teams coast-to-coast,” said Ross Hendry, Vice President of Consumer Sales and Marketing. “Philippe Dandurand has proven themselves, and truly understands the relationship between brand owners, provincial representatives and retail outlets, as well as how visibility and quality drive commercial success in a unique shopping environment.”

“At Velvet, we are committed to selling cannabis products of only the highest quality,” said Vianney Aubrecht, President of Velvet. “Pure Global has a commitment to premium products, and we look forward to driving sales through distribution, visibility and quality. This will ultimately benefit the customer who is navigating purchase decisions in a highly regulated environment but still looking for trusted super-premium and craft cannabis products,” added Aubrecht.

About Pure Global Cannabis

Pure Global Cannabis Inc. (TSX.V:PURE;OTC: PRCNF; FRA:1QS) is an innovation-based cannabis company led by experienced pharma, biotechnology, horticultural, and consumer packaged goods (CPG) experts. The Company’s wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Cannabis Act. The Company’s Brampton campus houses facilities for vertically farmed cultivation, R&D, extraction, manufacturing, and distribution. Pure Global will produce branded and white-labeled cannabis products for the medical, pharmaceutical, wellness, health & beauty, natural health, food & beverage, and recreational legal markets with uniquely formulated and purified concentrates. The Company is using the Canadian market as a springboard to develop and manufacture GMP-compliant cannabis products for international sale and distribution with a goal to become one of the most trusted premium international cannabis brands.

About Velvet Management

Velvet Management Inc. is a Canadian cannabis distribution company providing product sales and distribution to provincial liquor and cannabis boards across Canada. Velvet Management Inc. was created by the largest wine distributor in Canada, Philippe Dandurand Wines, the largest wine importer/agent in Canada, responsible for over 4 million cases or $625 million of sales volume across 3,000 retail points, with the largest wine salesforce in the country. Dandurand has been in operation since 1968, with 125 employees in its Calgary, Montreal, Toronto, and Vancouver, and has won Partner of the Year for the last three years by the LCBO.

This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global’s future plans and intentions.  Wherever possible, words such as “may”, “will”, “should”, “could”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict” or “potential” or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management’s current beliefs and are based on information currently available to management as at the date hereof.

Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully, and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

To register to Pure Global’s mailing list, please visit www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook and @pureglobalcannabis on Instagram.

For further information: regarding Pure Global, please contact: Stephen Pynn, VP Corporate Development, Telephone: 1-866-840-PURE (7873), E-mail: stephen@pureglobal.com; Malay Panchal, President & CEO, Telephone: 1-866-840-PURE (7873), E-mail: info@pureglobal.com

Click here to connect with Pure Global Cannabis Inc. (TSXV:PURE; OTC: PRCNF; FRA:1QS) for an Investor Presentation. 

Source: www.newswire.ca


Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant will be exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less


Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less